Sera Prognostics (SERA) Operating Leases (2022 - 2026)

Sera Prognostics' (SERA) quarterly Operating Leases came in at $2.5 million in Q1 2026, up 7.19% on a QoQ basis from $2.3 million in Q4 2025.

Sera Prognostics (SERA) Operating Leases (2022 - 2026) Analysis & Trends

Sera Prognostics (SERA) has 5 years of Operating Leases data on file, last reported at $2.5 million in Q1 2026.

Quarterly Operating Leases changed N/A year-over-year to $2.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.5 million (changed N/A YoY) and the FY2025 annual result came in at $2.3 million, changed N/A from the prior year.
Operating Leases rose to $2.5 million in Q1 2026, from $2.3 million in the prior quarter.
In the past five years, Operating Leases ranged from a high of $2.5 million in Q1 2026 to a low of $165000.0 in Q3 2024.
A 5-year average of $1.2 million and a median of $1.1 million in 2023 frame the typical range for Operating Leases.
Annual changes were most pronounced in 2024 — Operating Leases sank 85.01% — and 2025, when it jumped 1380.61%.
Tracing SERA's Operating Leases over 5 years: stood at $1.2 million in 2022, then plunged by 47.3% to $644000.0 in 2023, then sank by 74.38% to $165000.0 in 2024, then surged by 1316.36% to $2.3 million in 2025, then advanced by 7.19% to $2.5 million in 2026.
The last three Operating Leases figures came in at $2.5 million (Q1 2026), $2.3 million (Q4 2025), and $2.4 million (Q3 2025), per Business Quant data.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	198.70 Bn	193.10 Bn	7.27 Bn
2	Stryker	125.85 Bn	122.37 Bn	4.50 Bn
3	Medtronic	118.44 Bn	109.22 Bn	6.41 Bn
4	Boston Scientific	72.64 Bn	72.10 Bn	3.85 Bn
5	Edwards Lifesciences	51.94 Bn	47.69 Bn	1.35 Bn
6	Dexcom	34.48 Bn	32.53 Bn	830.00 Mn
7	GE HealthCare Technologies	33.60 Bn	31.49 Bn	2.18 Bn
8	Koninklijke Philips	26.30 Bn	22.98 Bn	4.55 Bn
9	Steris	23.00 Bn	22.52 Bn	684.20 Mn
10	Sera Prognostics	103.48 Mn	103.48 Mn	-20,000.00

Download Data